These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6822640)

  • 1. Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake.
    Gordon MB; Moore TJ; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1983 Feb; 56(2):340-5. PubMed ID: 6822640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin.
    Carey RM
    J Clin Endocrinol Metab; 1982 Feb; 54(2):463-9. PubMed ID: 6274907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G; Catt KJ
    Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of dopamine in nonmodulating hypertension.
    Gordon MS; Steunkel CA; Conlin PR; Hollenberg NK; Williams GH
    J Clin Endocrinol Metab; 1989 Aug; 69(2):426-32. PubMed ID: 2753983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
    Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
    J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension.
    Anderson GH; Howland T; Domschek R; Streeten DH
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1126-35. PubMed ID: 3760114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
    Sowers JR; Glub MS; Eggena PH; Catania RA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin.
    Malchoff CD; Hughes JM; Carey RM
    J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
    Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
    J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
    Carey RM; Vaughan ED; Peach MJ; Ayers CR
    J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic blockade of the renin-angiotensin-aldosterone system: effect of high and low sodium intakes.
    Gordon MB; Moore TJ; Dluhy RG; Williams GH
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):415-25. PubMed ID: 6354522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished aldosterone responses to angiotensin II and adrenocorticotropin in hypocalcemic subjects: restoration of responsiveness with normocalcemia.
    Brickman AS; Trujillo AL; Gutin MS; Tuck ML
    J Clin Endocrinol Metab; 1987 Feb; 64(2):297-303. PubMed ID: 3025245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine and nonmodulating hypertension.
    Williams GH; Gordon MS; Stuenkel CA; Conlin PR; Hollenberg NK
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):112S-115S. PubMed ID: 2383375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine modulates sodium-dependent aldosterone responses to angiotensin II in humans.
    Drake CR; Carey RM
    Hypertension; 1984; 6(2 Pt 2):I119-23. PubMed ID: 6373591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic suppression of angiotensin II-induced aldosterone secretion in man: differential responses during sodium loading and depletion.
    Drake CR; Ragsdale NV; Kaiser DL; Carey RM
    Metabolism; 1984 Aug; 33(8):696-702. PubMed ID: 6379373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of tissue responsiveness to angiotensin-II in hyperprolactinemic subjects.
    Arafah BM; Gordon NH; Salazar R; Douglas JG
    J Clin Endocrinol Metab; 1990 Jul; 71(1):60-6. PubMed ID: 2370301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypoparathyroidism.
    Sowers JR; Brickman AS; Asp N; Tuck ML; Jasberg K; Magnone S
    J Clin Endocrinol Metab; 1981 May; 52(5):914-8. PubMed ID: 7014587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma aldosterone response to angiotensin II in sodium-restricted elderly subjects with essential hypertension.
    Morimoto S; Uchida K; Miyamoto M; Kigoshi T; Morise T; Takimoto H; Takeda R
    J Am Geriatr Soc; 1981 Jul; 29(7):302-7. PubMed ID: 7016959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.